Citadel Advisors
FBT icon

Citadel Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Citadel Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,102
Closed -$5.22M – 13055
2025
Q3 		$4.68M Buy
26,102
+20,423
+360% +$3.48M ﹤0.01% 4484
2025
Q2 		$916K Sell
5,679
-21,841
-79% -$3.48M ﹤0.01% 7298
2025
Q1 		$4.68M Sell
27,520
-19,408
-41% -$3.37M ﹤0.01% 3982
2024
Q4 		$7.8M Buy
46,928
+29,387
+168% +$5.02M ﹤0.01% 3291
2024
Q3 		$3.02M Sell
17,541
-12,993
-43% -$2.15M ﹤0.01% 4771
2024
Q2 		$4.7M Buy
30,534
+12,719
+71% +$1.91M ﹤0.01% 3842
2024
Q1 		$2.74M Sell
17,815
-4,691
-21% -$715K ﹤0.01% 4941
2023
Q4 		$3.56M Buy
22,506
+1,846
+9% +$265K ﹤0.01% 4345
2023
Q3 		$3.02M Sell
20,660
-10,829
-34% -$1.65M ﹤0.01% 4468
2023
Q2 		$4.82M Buy
31,489
+14,386
+84% +$2.24M ﹤0.01% 3708
2023
Q1 		$2.65M Sell
17,103
-8,615
-33% -$1.35M ﹤0.01% 4843
2022
Q4 		$3.96M Buy
25,718
+14,356
+126% +$2.12M ﹤0.01% 4256
2022
Q3 		$1.5M Buy
11,362
+8,732
+332% +$1.23M ﹤0.01% 6158
2022
Q2 		$357K Sell
2,630
-41,574
-94% -$5.73M ﹤0.01% 9417
2022
Q1 		$6.59M Buy
44,204
+11,951
+37% +$1.77M ﹤0.01% 3648
2021
Q4 		$5.22M Sell
32,253
-15,982
-33% -$2.58M ﹤0.01% 4214
2021
Q3 		$8.01M Buy
48,235
+13,515
+39% +$2.31M ﹤0.01% 3454
2021
Q2 		$5.99M Buy
34,720
+1,169
+3% +$193K ﹤0.01% 4064
2021
Q1 		$5.38M Sell
33,551
-842
-2% -$144K ﹤0.01% 4099
2020
Q4 		$5.78M Sell
34,393
-374
-1% -$60.7K ﹤0.01% 3436
2020
Q3 		$5.47M Buy
34,767
+14,822
+74% +$2.42M ﹤0.01% 3022
2020
Q2 		$3.35M Buy
19,945
+9,393
+89% +$1.47M ﹤0.01% 3674
2020
Q1 		$1.38M Sell
10,552
-3,040
-22% -$433K ﹤0.01% 4764
2019
Q4 		$2.02M Sell
13,592
-5,568
-29% -$765K ﹤0.01% 4409
2019
Q3 		$2.37M Sell
19,160
-381
-2% -$50.7K ﹤0.01% 4219
2019
Q2 		$2.75M Buy
19,541
+11,362
+139% +$1.57M ﹤0.01% 3995
2019
Q1 		$1.23M Sell
8,179
-19,085
-70% -$2.75M ﹤0.01% 5220
2018
Q4 		$3.39M Buy
27,264
+22,012
+419% +$3.01M ﹤0.01% 3347
2018
Q3 		$832K Sell
5,252
-2,721
-34% -$412K ﹤0.01% 5852
2018
Q2 		$1.12M Sell
7,973
-22,226
-74% -$3.05M ﹤0.01% 5024
2018
Q1 		$4.01M Buy
30,199
+28,147
+1,372% +$3.84M ﹤0.01% 2711
2017
Q4 		$256K Buy
+2,052
New +$254K ﹤0.01% 6704
2017
Q3 		– Sell
-23,444
Closed -$2.77M – 7657
2017
Q2 		$2.67M Sell
23,444
-2,030
-8% -$218K ﹤0.01% 2792
2017
Q1 		$2.68M Buy
25,474
+13,101
+106% +$1.31M ﹤0.01% 2722
2016
Q4 		$1.12M Sell
12,373
-9,769
-44% -$915K ﹤0.01% 3702
2016
Q3 		$2.21M Sell
22,142
-6,391
-22% -$627K ﹤0.01% 2850
2016
Q2 		$2.55M Buy
28,533
+4,160
+17% +$382K ﹤0.01% 2483
2016
Q1 		$2.13M Buy
+24,373
New +$2.15M ﹤0.01% 2574
2015
Q4 		– Sell
-92,796
Closed -$9.4M – 8838
2015
Q3 		$9.4M Buy
+92,796
New +$11M 0.01% 1391
2015
Q1 		– Sell
-43,915
Closed -$4.48M – 8611
2014
Q4 		$4.48M Buy
+43,915
New +$4.29M ﹤0.01% 2082

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Citadel Advisors's FBT Position: Q4 2025 in Review

Citadel Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2025, closing a stake of 26,102 shares — an estimated $5.22M sold.

Citadel Advisors first reported a position in FBT in Q4 2014 and held it in 40 quarters. The position peaked at $9.4M in Q3 2015. 279 funds tracked by Wall St. Rank hold FBT as of Q4 2025.

  • Citadel Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 26,102 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2025, an estimated $5.22M.
  • Citadel Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 40 quarters.
  • Citadel Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.4M in Q3 2015.
  • 279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.